Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DAIO NYSE:INTT NASDAQ:NAUT NASDAQ:PRE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDAIOData I/O$3.21+1.7%$2.83$1.88▼$3.24$29.61M0.9826,230 shs13,852 shsINTTinTEST$7.23+2.6%$6.72$5.24▼$11.80$90.40M1.6549,642 shs5,149 shsNAUTNautilus Biotechnology$0.75-0.1%$0.76$0.66▼$3.09$94.36M1.42162,137 shs196,690 shsPREPrenetics Global$8.09-4.0%$8.05$3.09▼$11.99$98.69M0.1522,668 shs35,365 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDAIOData I/O-1.25%+1.94%+11.70%+58.69%+13.31%INTTinTEST-0.28%-12.09%+2.77%+17.50%-39.80%NAUTNautilus Biotechnology+3.99%-7.90%+3.99%-1.23%-72.58%PREPrenetics Global+2.06%+4.21%+20.11%+112.09%+39.40%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDAIOData I/O1.6048 of 5 stars2.05.00.00.02.51.70.0INTTinTEST3.3895 of 5 stars3.35.00.00.00.63.31.3NAUTNautilus Biotechnology2.9933 of 5 stars2.55.00.00.01.94.20.6PREPrenetics Global0.9382 of 5 stars1.53.00.00.02.10.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDAIOData I/O 4.00Strong Buy$5.2262.87% UpsideINTTinTEST 2.67Moderate Buy$12.0065.98% UpsideNAUTNautilus Biotechnology 1.00Sell$2.13184.09% UpsidePREPrenetics Global 3.00Buy$9.0011.30% UpsideCurrent Analyst Ratings BreakdownLatest DAIO, NAUT, PRE, and INTT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/8/2025DAIOData I/OWestpark CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$5.225/5/2025INTTinTESTNorthland CapmkSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/5/2025INTTinTESTLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$10.00 ➝ $8.00(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDAIOData I/O$21.85M1.36N/AN/A$1.91 per share1.68INTTinTEST$127.50M0.71$1.26 per share5.75$7.92 per share0.91NAUTNautilus BiotechnologyN/AN/AN/AN/A$1.66 per shareN/APREPrenetics Global$41.52M2.38N/AN/A$14.04 per share0.58Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDAIOData I/O-$3.09M-$0.29N/A∞N/A-12.21%-14.56%-10.84%7/24/2025 (Estimated)INTTinTEST$9.34M-$0.0131.4618.08N/A2.33%5.31%3.42%N/ANAUTNautilus Biotechnology-$70.78M-$0.54N/AN/AN/AN/A-31.87%-27.39%7/29/2025 (Estimated)PREPrenetics Global-$46.30M-$3.99N/AN/AN/A-115.91%-28.07%-22.27%N/ALatest DAIO, NAUT, PRE, and INTT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025Q2 2025NAUTNautilus Biotechnology-$0.14N/AN/AN/AN/AN/A6/12/2025Q1 2025PREPrenetics GlobalN/A-$0.80N/A-$0.80N/A$17.31 million5/2/2025Q1INTTinTEST-$0.10-$0.11-$0.01N/AN/AN/A4/29/2025Q1 2025NAUTNautilus Biotechnology-$0.14-$0.13+$0.01-$0.13N/AN/A4/24/2025Q1 2025DAIOData I/O-$0.09-$0.04+$0.05-$0.04$5.30 million$6.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDAIOData I/ON/AN/AN/AN/AN/AINTTinTESTN/AN/AN/AN/AN/ANAUTNautilus BiotechnologyN/AN/AN/AN/AN/APREPrenetics Global$2.8034.63%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDAIOData I/ON/A4.203.04INTTinTEST0.082.261.38NAUTNautilus BiotechnologyN/A17.3617.36PREPrenetics GlobalN/A2.071.89Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDAIOData I/O36.95%INTTinTEST63.18%NAUTNautilus Biotechnology50.71%PREPrenetics Global25.01%Insider OwnershipCompanyInsider OwnershipDAIOData I/O2.60%INTTinTEST7.00%NAUTNautilus Biotechnology41.10%PREPrenetics Global7.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDAIOData I/O1009.24 million9.00 millionOptionableINTTinTEST32012.50 million11.69 millionOptionableNAUTNautilus Biotechnology130126.15 million74.30 millionOptionablePREPrenetics Global112.21 million11.25 millionNot OptionableDAIO, NAUT, PRE, and INTT HeadlinesRecent News About These CompaniesPrenetics Global Limited Adopts Bitcoin Treasury Strategy Amidst Market VolatilityJuly 17 at 7:52 AM | tipranks.comPRE Prenetics Global Limited - Seeking AlphaJuly 9, 2025 | seekingalpha.comPrenetics Global (NASDAQ:PRE) Upgraded by Wall Street Zen to "Hold" RatingJuly 5, 2025 | marketbeat.comPrenetics Global Limited (PRE) - Yahoo FinanceJune 30, 2025 | finance.yahoo.comAryna Sabalenka Adds Her Muscle to IM8 as Ambassador & ShareholderJune 30, 2025 | msn.comAryna Sabalenka Becomes First Current Athlete Shareholder in Prenetics' IM8 Supplements BrandJune 26, 2025 | quiverquant.comQWorld No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and ShareholderJune 26, 2025 | globenewswire.comCardone Capital goes all-in on Bitcoin adding 1K BTC to its reserveJune 23, 2025 | msn.com$1.24 Billion in Bitcoin Added to Corporate Treasuries This WeekJune 22, 2025 | coingape.comCA South Korean Biotech Firms Gets $183.3M Funding to Build Bitcoin TreasuryJune 21, 2025 | coindesk.comHealthcare Meets Crypto: David Beckham–Backed Prenetics Launches $20M Bitcoin TreasuryJune 20, 2025 | techstory.inTPrenetics Global (NASDAQ:PRE) Stock, Short Interest ReportJune 19, 2025 | benzinga.comPrenetics Adopts $20M Bitcoin Treasury StrategyJune 19, 2025 | thecurrencyanalytics.comTPrenetics Global First Quarter 2025 Earnings: Revenues Beat Expectations, EPS In LineJune 19, 2025 | finance.yahoo.comPrenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to BoardJune 18, 2025 | globenewswire.comPrenetics Global Limited Divests ACT Genomics, Strengthens Financial Position and Raises FY2025 Revenue OutlookJune 18, 2025 | quiverquant.comQPrenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million TransactionJune 18, 2025 | globenewswire.comPrenetics Global Limited Appoints New Independent Director to Strengthen Bitcoin StrategyJune 16, 2025 | tipranks.comPrenetics Global reports Q1 2025 financialsJune 14, 2025 | uk.investing.comPrenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement SoonJune 14, 2025 | nasdaq.comPrenetics Global Full Year 2024 Earnings: Misses ExpectationsMay 3, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhich Analyst-Favorite Drone Stock Will Come Out on Top?By Nathan Reiff | June 25, 2025View Which Analyst-Favorite Drone Stock Will Come Out on Top?Why Wall Street Is Betting on These 3 Comeback StocksBy Nathan Reiff | July 12, 2025View Why Wall Street Is Betting on These 3 Comeback StocksChime’s Smart IPO: Half the Valuation, Double the StrengthBy Jeffrey Neal Johnson | June 18, 2025View Chime’s Smart IPO: Half the Valuation, Double the StrengthJoby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?By Jeffrey Neal Johnson | July 14, 2025View Joby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?The Ultimate Trump Bump: These Gov't Backed Stocks Are ExplodingBy Leo Miller | July 2, 2025View The Ultimate Trump Bump: These Gov't Backed Stocks Are ExplodingDAIO, NAUT, PRE, and INTT Company DescriptionsData I/O NASDAQ:DAIO$3.20 +0.06 (+1.75%) As of 02:25 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Data I/O Corporation, together with its subsidiaries, engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in the United States, Europe, and internationally. Its programming system products are used to program integrated circuits (ICs) with the specific data for the ICs. The company offers PSV handlers off-line automated programming systems, such as PSV2800 automated programming system which focuses on high-volume manufacturing in a lower cost platform; PSV7000 automated programming system for security deployment upgrades; PSV5000 automated programming system that combines mid-range capacity and supports security deployment; and PSV3500 automated programming system which provides basic programming needs. It also provides SentriX security deployment system; and LumenX and non-automated FlashPAK III programming systems. In addition, the company offers hardware support, system installation and repair, and device programming services. It markets and sells its products to original equipment manufacturers in automotive and consumer electronics, internet of things, and industrial, as well as electronic manufacturing service contract manufacturers through direct sales, and indirect sales representatives and distributors. Data I/O Corporation was incorporated in 1969 and is headquartered in Redmond, Washington.inTEST NYSE:INTT$7.23 +0.18 (+2.55%) As of 02:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies. The Electronic Test segment offers in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly. This segment also provides tester interfaces that offer electrical connections between the tester and the wafer prober or IC handler; scorpion flying probe test systems that designs and manufactures robotics-based electronic test equipment; and BRiZ automated test and programming services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The Environmental Technologies segment provides ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; thermal chambers; thermal platforms; Thermonics temperature conditioning products that offer tempered gas or fluid; and ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions. The Process Technologies segment offers EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.Nautilus Biotechnology NASDAQ:NAUT$0.75 0.00 (-0.09%) As of 02:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.Prenetics Global NASDAQ:PRE$8.09 -0.33 (-3.97%) As of 02:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Citigroup Earnings Could Signal What’s Next for Markets This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
